Clinical Trial Update: Nicotine Substitute Prescribed at Hourly Intake or ad Libitum for Heavy Smokers Willing to Quit [Phase 4]

View source ↗

Summary

A Phase 4 trial conducted by the University of Lausanne evaluated nicotine replacement therapy administered hourly or ad libitum for heavy smokers willing to qu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• Nicotine replacement therapy (nicotine replacement therapy)

Snippet

Sponsor: University of Lausanne | Conditions: Smoking Cessation | Phase 4 | Status: COMPLETED